Helicobacter pylori eradication reduces risk for recurrence of gastric hyperplastic polyp after endoscopic resection
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Little is known about the effect of Helicobacter pylori eradication on the recurrence of gastric hyperplastic polyps after endoscopic resection. Thus, we evaluated the recurrence rate of gastric hyperplastic polyps based on H. pylori eradication following endoscopic resection. Methods: We retrospectively reviewed the medical records of 201 patients with H. pylori infection who underwent endoscopic resection for gastric hyperplastic polyps at six medical centers. H. pylori status was assessed by histological analysis and a rapid urease test. A total of 149 patients underwent successful H. pylori eradication (eradication group), whereas 52 patients had persistent H. pylori infections (non-eradication group). The recurrence rate of gastric hyperplastic polyps and the risk factors according to H. pylori status were analyzed. Results: During the mean follow-up period of 18.3 months, recurrent gastric polyps developed after endoscopic resection in 10 patients (19.2% [10/52]) in the non-eradication group and 12 patients (8.1% [12/149]) in the eradication group. The cumulative incidence of recurrent gastric hyperplastic polyps was significantly higher in the non-eradication group than in the eradication group (p = 0.041, log‐rank test). In the adjusted analysis, H. pylori eradication reduced the recurrence of gastric hyperplastic polyps (hazard ratio [HR], 0.42; 95% confidence interval [CI], 0.18 to 0.99), whereas anticoagulation therapy increased the risk of recurrence of gastric hyperplastic polyps (HR, 4.91; 95% CI, 1.39 to 17.28). Conclusions: Successful eradication of H. pylori may reduce the recurrence of gastric hyperplastic polyps in patients after endoscopic mucosal resection.
Abstract
Background/Aims: Little is known about the effect of Helicobacter pylori eradication on the recurrence of gastric hyperplastic polyps after endoscopic resection. Thus, we evaluated the recurrence rate of gastric hyperplastic polyps based on H. pylori eradication following endoscopic resection. Methods: We retrospectively reviewed the medical records of 201 patients with H. pylori infection who underwent endoscopic resection for gastric hyperplastic polyps at six medical centers. H. pylori status was assessed by histological analysis and a rapid urease test. A total of 149 patients underwent successful H. pylori eradication (eradication group), whereas 52 patients had persistent H. pylori infections (non-eradication group). The recurrence rate of gastric hyperplastic polyps and the risk factors according to H. pylori status were analyzed. Results: During the mean follow-up period of 18.3 months, recurrent gastric polyps developed after endoscopic resection in 10 patients (19.2% [10/52]) in the non-eradication group and 12 patients (8.1% [12/149]) in the eradication group. The cumulative incidence of recurrent gastric hyperplastic polyps was significantly higher in the non-eradication group than in the eradication group (p = 0.041, log‐rank test). In the adjusted analysis, H. pylori eradication reduced the recurrence of gastric hyperplastic polyps (hazard ratio [HR], 0.42; 95% confidence interval [CI], 0.18 to 0.99), whereas anticoagulation therapy increased the risk of recurrence of gastric hyperplastic polyps (HR, 4.91; 95% CI, 1.39 to 17.28). Conclusions: Successful eradication of H. pylori may reduce the recurrence of gastric hyperplastic polyps in patients after endoscopic mucosal resection.
참고문헌 (29)
- Park DY, "Gastric polyps : classification and management", Arch Pathol Lab Med, 132, pp.633~640 (2008)
- Jain R, "Gastric hyperplastic polyps : a review", Dig Dis Sci, 54, pp.1839~1846 (2009)
- Cheesman AR, "Current management of benign epithelial gastric polyps", Curr Treat Options Gastroenterol, 15, pp.676~690 (2017)
- Orlowska J, "Malignant transformation of benign epithelial gastric polyps", Am J Gastroenterol, 90, pp.2152~2159 (1995)
- Shaib YH, "Management of gastric polyps : an endoscopy-based approach", Clin Gastroenterol Hepatol, 11, pp.1374~1384 (2013)
- ASGE Standards of Practice Committee, "The role of endoscopy in the management of premalignant and malignant conditions of the stomach", Gastrointest Endosc, 82, pp.1~8 (2015)
- Ji F, "Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori : a randomized, controlled trial", World J Gastroenterol, 12, pp.1770~1773 (2006)
- Ohkusa T, "Endoscopic, histological and serologic findings of gastric hyperplastic polyps after eradication of Helicobacter pylori : comparison between responder and non-responder cases", Digestion, 68, pp.57~62 (2003)
- Ohkusa T, "Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori : a randomized, clinical trial", Ann Intern Med, 129, pp.712~715 (1998)
- Asaka M, "Guidelines for the management of Helicobacter pylori infection in Japan : 2009 revised edition", Helicobacter, 15, pp.1~20 (2010)
- Goddard AF, "The management of gastric polyps", Gut, 59, pp.1270~1276 (2010)
- 김상균, "한국인 헬리코박터 파일로리 감염의 진단과 치료 임상 진료지침 개정안 2013", 대한소화기학회지, 62(1), pp.3~26 (2013), 대한소화기학회
- Nam SY, "Helicobacter pylori eradication regressed gastric hyperplastic polyp : a randomized controlled trial", Dig Dis Sci, 65, pp.3652~3659 (2020)
- Yasunaga Y, "Increased production of interleukin 1 beta and hepatocyte growth factor may contribute to foveolar hyperplasia in enlarged fold gastritis", Gut, 39, pp.787~794 (1996)
- Bamba H, "Expression of cyclooxygenase-2in human hyperplastic gastric polyps", J Exp Clin Cancer Res, 22, pp.425~430 (2003)
- Nakajima A, "Details of hyperplastic polyps of the stomach shrinking after anti-Helicobacter pylori therapy", J Gastroenterol, 35, pp.372~375 (2000)
- Lipkin M, "Tritiated-thymidine labeling of rectal epithelial cells in ‘non-prep’ biopsies of individuals at increased risk for colonic neoplasia", Cancer Lett, 37, pp.153~161 (1987)
- Bechi P, "Helicobacter pylori and cell proliferation of the gastric mucosa : possible implications for gastric carcinogenesis", Am J Gastroenterol, 91, pp.271~276 (1996)
- Nam SY, "Effect of Helicobacter pylori infection and its eradication on the fate of gastric polyps", Eur J Gastroenterol Hepatol, 28, pp.449~454 (2016)
- 강규호, "과형성 위용종의 내시경적 제거 후 헬리코박터 파일로리 감염 상태에 따른 위용종 재발률", 대한소화기학회지, 71(4), pp.213~218 (2018), 대한소화기학회[DOI]
- Shin SH, "Helicobacter pylori eradication prevents metachronous gastric neoplasms after endoscopic resection of gastric dysplasia", PLoS One, 10, pp.e0143257~ (2015)
- 전일영, "Effect of Helicobacter pylori Eradication on Subsequent Dysplasia Development after Endoscopic Resection of Gastric Dysplasia", 대한소화기학회지, 61(6), pp.307~312 (2013), 대한소화기학회
- Dirschmid K, "Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa?", Virchows Arch, 448, pp.80~84 (2006)
- Abraham SC, "Hyperplastic polyps of the stomach : associations with histologic patterns of gastritis and gastric atrophy", Am J Surg Pathol, 25, pp.500~507 (2001)
- Castro R, "Evaluation and management of gastric epithelial polyps", Best Pract Res Clin Gastroenterol, 31, pp.381~387 (2017)
- 남수연, "Effect of Helicobacter pylori eradication on the regression of gastric polyps in National Cancer Screening Program", The Korean Journal of Internal Medicine, 33(3), pp.506~511 (2018), 대한내과학회[DOI]
- Hsieh JY, "Differential regulation of macrophage inflammatory activation by fibrin and fibrinogen", Acta Biomater, 47, pp.14~24 (2017)
- Negron O, "Fibrin(ogen)engagement of S. aureus promotes the host antimicrobial response and suppression of microbe dissemination following peritoneal infection", PLoS Pathog, 18, pp.e1010227~ (2022)
- Ikeda A, "Presence of thrombin-activatable fibrinolysis inhibitor in Helicobacter pylori-associated gastroduodenal disease", Helicobacter, 14, pp.147~155 (2009)